Why the study?
Does angiotensin-converting enzyme inhibition therapy improve renal hemodynamics, proteinuria, and pathological lesions in spontaneously hypertensive rats compared to hydrochlorothiazide?
Population
Aged spontaneously hypertensive rats with naturally occurring end-stage renal disease and younger, adult SHR…
Comparison
Angiotensin-converting enzyme inhibition therapy vs Hydrochlorothiazide
Design
Preclinical
Authors
Loading...
No immediate change to hypertension management; extends evidence for ACE inhibitor-specific renal benefits in hypertensive models.
Does angiotensin-converting enzyme inhibition therapy improve renal hemodynamics, proteinuria, and pathological lesions in spontaneously hypertensive rats compared to hydrochlorothiazide?
ACE inhibition, but not hydrochlorothiazide, prevents or reverses renal pathological lesions and proteinuria in spontaneously hypertensive rats, suggesting specific intrarenal benefits beyond blood pressure lowering.
Edward D. Fröhlich (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: